Haleon plc Stock price

Equities

HLN

GB00BMX86B70

Pharmaceuticals

Real-time Estimate Cboe Europe 11:30:00 2024-02-29 am EST 5-day change 1st Jan Change
332.9 GBX +6.04% Intraday chart for Haleon plc +1.85% +3.39%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Sales 2023 * 11.29B 14.3B Sales 2024 * 11.54B 14.62B Capitalization 28.99B 36.72B
Net income 2023 * 1.44B 1.83B Net income 2024 * 1.58B 2B EV / Sales 2023 * 3.33 x
Net Debt 2023 * 8.57B 10.85B Net Debt 2024 * 7.39B 9.36B EV / Sales 2024 * 3.15 x
P/E ratio 2023 *
19.7 x
P/E ratio 2024 *
17.9 x
Employees 24,622
Yield 2023 *
1.72%
Yield 2024 *
1.87%
Free-Float 66.36%
More Fundamentals * Assessed data
Dynamic Chart
1 day+6.47%
1 week+1.94%
Current month+3.53%
1 month+3.80%
3 months+0.53%
6 months+1.91%
Current year+3.48%
More quotes
1 week
312.15
Extreme 312.15
342.15
1 month
312.15
Extreme 312.15
342.15
Current year
310.45
Extreme 310.45
342.15
1 year
306.50
Extreme 306.5
357.65
3 years
241.17
Extreme 241.1735
357.65
5 years
241.17
Extreme 241.1735
357.65
10 years
241.17
Extreme 241.1735
357.65
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 21-07-21
Director of Finance/CFO 52 21-11-30
Chief Tech/Sci/R&D Officer - 21-12-15
Members of the board TitleAgeSince
Director/Board Member - 22-07-17
Director/Board Member 63 22-07-17
Director/Board Member 57 22-07-17
More insiders
Date Price Change Volume
24-02-29 332.6 +5.92% 16 928 169
24-02-28 314 -2.52% 18,448,250
24-02-27 322 -0.68% 14,396,950
24-02-26 324.2 -0.93% 17,137,720
24-02-23 327.3 +0.25% 12,997,990

Delayed Quote London S.E., February 29, 2024 at 09:24 am EST

More quotes
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (19.3%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc; - vitamins, minerals and food supplements (15.4%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - respiratory medicines (14.6%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc. Net sales are distributed geographically as follows: the United Kingdom (3.2%), Europe/Middle East/Africa/Latin America (36.1%), the United States (34%), North America (3.9%), China (8.6%) and Asia/Pacific (14.2%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.14 GBP
Average target price
3.607 GBP
Spread / Average Target
+14.90%
Consensus
  1. Stock
  2. Equities
  3. Stock Haleon plc - London S.E.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW